Precision Medicine

Seek fast-track
drug development

Using our pioneering eXplainable AI platform KEM® we design and execute Precision Medicine clinical trials, with an unparalleled successful track record across multiple therapeutic areas. Thanks to our XAI KEM® platform we integrate extensive pre-clinical, clinical as well as Real World Evidence data, to define best dose, identify patient selection and surrogate endpoint biomarkers as well as alternative clinical indications. Our Precision Medicine clinical protocols allow for extensive data collection and use of stratification biomarkers, enabling accelerated approval regulatory pathways.

Our technology matches all steps of clinical development and can be used even with small datasets of 10-20 patients.

  • PROVEN TRACK RECORD: + 20 years in AI and drug development
  • BROAD THERAPEUTIC DOMAINS
Section Image - Ariana Pharma

KEM®

XAI
ACCELERATED Clinical Drug Development Process

We Increase the Value of Clinical Assets

KEM® XAI
Integrate & Design

Accelerate path from design to approval

Precision
Medicine

Data rich protocols with pre-specified biomarkers

Generate Data

Multi-omic, immune profiling, questionnaires and other clinical data

Regulatory
Strategy

Transform findings into regulatory strategies

Ariana's Precision Medicine Approach

In The News

Latest news and case studies